Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial
2022 · Trials · 26 citations
https://doi.org/10.1186/s13063-022-06874-w
E
Eline J. Arends
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
23
Papers
220
Citations
8
h-index
6
i10-index
Eline J. Arends is an academic researcher from Leiden University Medical Center. The author has contributed to research in topics: Systemic Lupus Erythematosus Research & T-cell and B-cell Immunology & Monoclonal and Polyclonal Antibodies Research. The author has an h-index of 8, co-authored 20 publications.
ORCID: 0000-0003-4619-4077Papers by this author
worksResearch topics
topicsChat about Author
Papers
Chat
Click to start Chat